Interesting reading. What’s not visible unless you know is it’s the same drugs that were impacted by the consent decree a few years back. And head of quality was also very actively a significant part of that consent decree quality team too. But you can read the place is a disaster and it’s not wrong. Understaffed. Not learning lessons. Place is out of control. Perhaps another CD coming ?Just published on fda website today
Driven by McKinsey processes. Look what happened to Boeing when they followed they same path…Attrition. Everywhere. Learning gaps. Everywhere. There IS a price to pay for the global cost/people cutting. Impacting all phases, but only hearing of this mess because FDA inspected. If they looked behind Sanofi curtains anywhere, any department right now they’d see the mess.